FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Golden State Medical Supply PAROXETINE tablets Recall

PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Dec 6, 2023
Recall ID
D-0129-2024
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled PAROXETINE tablets starting Nov 10, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0129-2024 on Dec 6, 2023. Reason: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Product description

PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

Lot numbers, UPCs & expiration codes

Lot # a) GS036696, GS037068, GS037934, GS038564, Exp. 08/31/2024 b) GS036381, GS036712, GS037116, GS037692, GS038388, Exp. 08/31/2024;

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0129-2024
Classification
Class II
Status
Terminated
Recall initiated
Nov 10, 2023
FDA report date
Dec 6, 2023
Quantity
2502 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-0129-2024, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Terminated
Country
United States
Event ID
93431
Address
5187 Camino Ruiz
Code information
Lot # a) GS036696, GS037068, GS037934, GS038564, Exp. 08/31/2024 b) GS036381, GS036712, GS037116, GS037692, GS038388, Exp. 08/31/2024;
Postal code
93012-8601
Report date
Dec 6, 2023
Product type
Drugs
Recall number
D-0129-2024
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
2502 bottles
Termination date
Mar 21, 2025
Reason for recall
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Voluntary / mandated
Voluntary: Firm initiated
Product description
PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 10, 2023
Initial firm notification
Letter
Center classification date
Nov 30, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0129-2024, published Dec 6, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls